| Trial ID: | L4143 |
| Source ID: | NCT05754424
|
| Associated Drug: |
At278
|
| Title: |
AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp Study
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: AT278|DRUG: NovoRapid|DRUG: Humulin R 500 UNT/ML Injectable Solution
|
| Outcome Measures: |
Primary: Area under the glucose infusion rate-time curve of insulin aspart, 0 to 60 minutes |
|
| Sponsor/Collaborators: |
Sponsor: Arecor Limited
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
41
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2023-02-27
|
| Completion Date: |
2024-02-12
|
| Results First Posted: |
|
| Last Update Posted: |
2024-02-16
|
| Locations: |
Clinical Trials Unit, Medical University of Graz, Graz, Austria
|
| URL: |
https://clinicaltrials.gov/show/NCT05754424
|
